China Resources Zizhu Pharmaceutical Co., Ltd., Yue Keting, one of the top ten brands of oral contraceptives, began in 1969, long-acting oral contraceptives, suitable for women who have given birth and have long-term contraceptive needs, and is a high-tech enterprise in the field of reproductive health in China
Levonosorgestrel ethinyl estradiol tablets (Yueketing), which has the effect of inhibiting ovulation, is a long-acting oral contraceptive for women.
With more than 40 years of experience in the research and development of family planning drugs, China Resources Zizhu Pharmaceutical Co., Ltd. is a leading enterprise in the field of reproductive health drugs in China, and we are one of the first batch of backbone enterprises in the scale of the Beijing Biomedical Industry Leapfrog Development Project (G20 Project), and the company is a high-tech enterprise in Beijing as the Beijing Reproductive Contraceptive Drug Engineering Technology Research Center.
China Resources Zizhu Pharmaceutical Co., Ltd., formerly known as Beijing No. 3 Pharmaceutical Factory, was established in 1969, and the company has a first-class production plant in China and advanced pharmaceutical equipment in the world. Since 1962, with the promulgation of the document "Instructions on Seriously Promoting Family Planning" issued by the CPC Central Committee and the State Council, as well as the important instructions of Premier Zhou Enlai on family planning work, in 1969, the predecessor of China Resources Zizhu Pharmaceutical Co., Ltd., Beijing No. 3 Pharmaceutical Factory was established. It is a product system based on family planning drugs, reproductive health drugs, ophthalmic preparations, APIs and other series. As a leader in the field of reproductive health in China, the main products of emergency contraceptive pill Yuting and anti-early pregnancy drug mifepristone have always occupied a dominant position in the domestic market, with a domestic market share of 35.13% for contraceptive products and a domestic market share of 58% for the anti-early pregnancy drug mifepristone, and have been rated as Beijing famous brand products and Beijing high-quality products for many years. The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China was rated as an advanced unit of national quality work. From 1992 to 1998, the anti-early pregnancy drug mifepristone and the first emergency contraceptive pill in China, Yuting, were launched one after another.
The successful research and development of the company's family planning drug products has provided an advanced, convenient and safe emergency contraceptive method for the majority of women of childbearing age in China.
At the end of 2010, Zizhu Qinhuangdao raw material base, covering an area of more than 300 acres, was completed and put into operation, learning, learning, absorbing and introducing international leading production, management, technology and equipment, combined with Zizhu Pharmaceutical's technology and scale advantages in the field of steroid drug production, implementing an environmentally friendly process route to achieve "clean production", adhering to the concept of sustainable development and positioning steroid hormone series products in accordance with the policy of "high starting point" and "self-sufficient to outward-looking, step-by-step implementation and rolling development". Taking into account other varieties with relevant production technology, so that production and manufacturing can develop in harmony with the ecological environment, economic benefits and social responsibility.
The company's API products have started cos and FDA certification, and actively participate in the competition in the low-end market while breaking through the high-end market; In 2012, Qinhuangdao passed the WHO pre-qualification on-site inspection, and the zero 483 defective items passed the FDA's on-site inspection of the main varieties. Preparation products from the low-end market to explore overseas preparation sales methods, increase the sales of registered developing countries, and at the same time to the WHO and other international organizations and Europe and the United States high-end market development. At present, the company has completed the registration of 14 countries or regional organizations, and has more than 100 regular trade customers.
In 2012, the company acquired the latex business assets of Sinochem Group and reorganized the two enterprises of Guilin Latex and Shanghai Latex. On June 13, 2013, it was officially renamed China Resources Zizhu Pharmaceutical Co., Ltd.
